Reuters
Apple Loses Appeal Over 4G Patent Infringement in London Court, Optis Scores Another Victory
- Apple Inc (NASDAQ:AAPL) overstepped two telecommunications patents used in devices, including iPhones and iPads, London's Court of Appeal ruled on Tuesday, dismissing the iPhonemaker's appeal in a long-running dispute.
- Optis Cellular Technology LLC prosecuted Apple in 2019 over its use of patents, which Optis says are critical to specific technological standards, like 4G.
- The legal battle between Apple and Optis began in 2019, prompting six separate trials and several appellate hearings in Britain alone.
Deutsche Bank, Commerzbank Slammed With $348M Suit By Russian Gas Giant Subsidiary
- Deutsche Bank AG (NYSE:DB) and Commerzbank AG (OTC:CRZBF) (OTC:CRZBY) are slammed by a lawsuit worth ₽31 billion ($348 million) by RusKhimAlyans, a Russian gas giant Gazprom's subsidiary.
- In particular, RusKhimAlyans is asking for over ₽22 billion from Deutsche Bank and over ₽8 billion from Commerzbank, Reuters reported citing documents filed at the Court of Arbitration of St Petersburg and the Leningrad Region.
Nikola Seeks To Liquidate Battery Maker Romeo Power
- Nikola Corp (OTC:NKLA) stock is trading lower Wednesday after reports indicated its plans to liquidate the assets of battery maker Romeo Power less than a year after buying it.
- The electric truck maker struggled to satisfy investors amid overblown costs of commodities and tight access to capital since 2022.
Pfizer and South Korea's Samsung Biologics Ink $900M Partnership for Biosimilar Production: Details
- South Korean contract development and manufacturing organization Samsung Biologics and Pfizer Inc (NYSE:PFE) have signed two agreements for the long-term manufacturing of Pfizer's multiproduct biosimilar portfolio, worth $897 million.
- The two deals include a $193 million deal and a $704 million deal - Samsung Biologics' most significant single contract since its inception in 2011.
- Including a $183 million deal signed in March, the combined value of Samsung Biologics-Pfizer deals this year amounts to $1.08 billion.
Benzinga
Airbus Opens New Technology Hub At Filton Site To Design Wings For Next Generation Aircrafts
What Can Drive TSMC's Revenue Rebound? Strong Demand for AI Chips from Nvidia, Broadcom, AMD
Rivian Automotive Reported Q2 Production, Delivery Numbers
Evotec Secures US Government Contract For Orthopoxvirus Antibody
Mondelēz Recalls Two Varieties Of belVita Biscuits In US Over Peanut Contamination
Warren Buffett-Backed BYD Plans To Invest $620M In Brazil's Camaçari Industrial Complex
Bloomberg
Alibaba Conducts Strategic Review of Youku and Tudou Amidst Rivalry with Baidu and Tencent
UPS Drivers Consider Going On Strike, After Failed Labor Talks
OMV-ADNOC In Talks To Create Over $30B Chemicals & Plastics Firm
Photo via Wikimedia Commons
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
